We are monitoring the impact of COVID-19 on Deep Brain Stimulation Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 11509
Share on
Share on

Global Deep Brain Stimulation Market Size, Share, Trends, Growth, COVID-19 Impact Analysis Report – Segmented By Product, Type, Application, End-Use and Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 11509
Pages: 180

Global Deep Brain Stimulation Market Size (2021 to 2026)

The global deep brain stimulation market size is estimated to be growing at a CAGR of 10.5% between 2021 to 2026.

Deep brain stimulation is a type of surgery in which an electrode is inserted in the brain and delivers electric signals to the brain that controls body activity. The electrodes or leads of the system produce electrical impulses that control irregular impulses. These impulses also correct chemical imbalances in the brain that affect a variety of diseases. A pacemaker-like device implanted under the skin in the upper chest controls the amount of relaxation of deep brain stimulation. This system is connected to the electrodes in the brain by a wire that runs beneath the skin. Deep brain stimulation consists of four components: electrodes inserted in the brain, a pacemaker-like system known as a pulse generator, extension leads that hold electrical pulses, and a handheld programmer device that adjusts the device's signals.

MARKET DRIVERS:

Y-O-Y rise in the prevalence of neurological disorders and technological advancement drives the global deep brain stimulation market growth.

Deep brain stimulators can treat neurological disorders such as Parkinson's disease, epilepsy, and depression. According to the World Health Organization, neurological disorders account for 6.3 % of the disease burden. They are one of the leading causes of death globally, accounting for 13.2 % in developing nations and 16.8 % in low- and middle-income countries. Furthermore, on than 264 million people of all ages worldwide suffer from depression. According to the Parkinson's Foundation, more than 10 million people globally have Parkinson's disease, with almost one million people in the United States suffering from the disease (PD). Furthermore, Epilepsy, a progressive noncommunicable brain disease, affects about 50 million individuals globally, with about 80 % of those living in low- and middle-income countries, according to WHO.

Deep brain stimulator technological advances also raise demand for the deep brain stimulator business. Many industry players are developing innovations in deep brain stimulator technologies to reduce side effects, which raises the rate of deep brain stimulator adoption. E.g., on June 26, 2020, Medtronic announced the launch of PerceptTM PC Neurostimulator with BrainsenseTM Technology, an improved deep brain stimulation (DBS) device. The use of the new device is the first to deliver electrical stimuli to the brain to alleviate Parkinson's disease (PD) symptoms and monitor the results of the brain's electrical activity. Such technical developments, such as new electrode designs with segmented contacts for multi-target stimulation, the availability of directional electrodes, novel stimulation waveform forms, neuroimaging advances to improve targeting, and novel temporal patterns of stimulation, reduce the side effects of deep brain stimulators to some degree and increase the acceptance rate of deep brain stimulators. Furthermore, robotic innovation in deep brain stimulator surgery reduces accumulated error positively and productively, resulting in accurate implantation of deep brain stimulator electrodes. All of these developments boost the demand for deep brain stimulators shortly also.

MARKET RESTRAINTS:

Nonetheless, the high cost of surgery and a scarcity of clinicians to perform deep brain stimulator surgery hinder the global deep brain stimulation market.

COVID-19 impact on the global deep brain stimulation market:

People with chronic illnesses, such as Parkinson's Disease (PD) and other neurological conditions, are at a higher risk of infection. Covid-19 demonstrates a high infection rate in Parkinson's disease patients, rising demand for deep brain stimulator surgeries. Furthermore, covid -19 has an impact on psychological behavior. Fear of work loss, anxiety, and sleeping disturbances all contribute to an uptick in the prevalence rate of neurological disorders, necessitating deep brain stimulator surgeries. Besides, since coronavirus patients overload nearly all hospitals, patients who have experienced deep brain stimulation (DBS) choose the telemedicine deep brain stimulator facility to preserve social distance.  

The deep brain stimulation market has a promising effect in some of these ways, but in some places where the Deep Brain Stimulation Market has faced difficulties due to covid – 19. This pandemic has imposed quarantine worldwide, making it impossible to travel outdoors, putting people with chronic diseases, such as Parkinson's disease (PD), at a healthcare disadvantage, who need regular follow-up due to lack of public transportation. Furthermore, people with deep brain stimulation may have difficulty visiting their physicians for programming and battery replacement in battery problems because it is not considered a healthcare emergency. Aside from that, with the growing number of coronavirus patients and their death rates, hospitals devote more energy to treating infected patients. As a result, public health recommendations have advised that elective surgical treatments, such as deep brain stimulation (DBS) surgery for Parkinson's disease (PD), be avoided during the coronavirus (COVID-19) pandemic to deter further viral transmission and to overburden of healthcare facilities.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product, Type, Application, End-Use, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities, and COVID-19 Impact

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This market research report on the global deep brain stimulation market has been segmented and sub-segmented based on type, application, end-use, and region.

Global Deep Brain Stimulation Market - By Product:

  • Single Channel
  • Dual-Channel

Based on the product type, due to higher penetration in surgical procedures, the dual-channel segment led the deep brain stimulation market in 2020, with a revenue share of 60%. Dual-channel surgery is one of the most advanced and successful surgical techniques available.  As a result, the segment is being driven by the high prevalence of debilitating neurological disorders, a rising number of surgical operations for Parkinson's disease, and an increasing number of hospitals using dual-channel DBS systems.

Global Deep Brain Stimulation Market - By Type:

  • Subthalamic DBS
  • Globus Pallidus DBS
  • Thalamic DBS
  • Pedunculopontine Nucleus DBS

By type, the subthalamic DBS segment is predicted to lead the global deep brain stimulation market during the forecast period. Growing government support and raising awareness over the availability of different techniques in healthcare are leveling up the demand of the market. The Globus pallidus DBS segment is growing at a higher rate in the coming years.

Global Deep Brain Stimulation Market - By Application:

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Obsessive-Compulsive Disorder (OCD)
  • Depression
  • Dystonia
  • Parkinson’s Disease
  • Others

Based on the application, Parkinson's disease was the market leader in the global deep brain stimulation market in 2020, with a market share of 65.2 percent, due to the rising number of FDA approvals for deep brain stimulation treatment in the United States and the high prevalence of PD globally. The Verse deep brain stimulation device system was approved by the US Food and Drug Administration to treat Parkinson's disease. Around 60,000 individuals in the United States are diagnosed with Parkinson's disease each year, according to the Parkinson's Foundation, and this is predicted to accelerate category growth.

Global Deep Brain Stimulation Market - By End-Use:

  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centres
  • Research Centres

In 2020, the segment of hospitals was forecasted to dominate among all types during the forecast period. The growth of this category is being driven by an increase in the number of DBS operations performed in hospitals and an increase in the incidence of Parkinson's disease and critical tremors.

Global Deep Brain Stimulation Market – By Region:

  • North America
    • The U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Rest of Latin America
  • Middle East
  • Africa

Geographically, the North American deep brain stimulation market is expected to dominate the global deep brain stimulation market during the forecast period and accounted for more than 50% of the market share in 2020. Factors such as rising FDA approval for deep brain stimulation devices in clinical applications strongly favor this regional market. In North America, the U.S. accounted for the largest share and dominated the regional market. The need for deep brain stimulation equipment in the country is being driven by an increase in the number of patients with Parkinson's disease and increased federal support and campaigns to raise awareness about movement disorders. On the other hand, the Canadian market is anticipated to contribute to the North American regional market's moderated share in the coming years.

The European deep brain stimulation market was the second-largest regional market in the world in 2020 and is predicted to have a promising growth rate during the forecast period. The increasing prevalence of neurological disorders, the adoption of advanced technology in the healthcare sector, and developed healthcare infrastructure boost the market growth in the region. The major contributors in the region are the UK, Germany, Spain, and Italy. The UK dominated the regional market and accounted the significant market growth.

However, the APAC deep brain stimulation market is one of the fastest developing regions globally in the global deep brain stimulation devices market between 2021 and 2026. Key market players are focussing on approval and launch of novel DBS devices to expand their product portfolio, which is likely to improve the market growth. Emerging countries such as India, China, and Japan are contributing to the regional market growth. The China market accounted for the leading share in the APAC market in 2020. China witnessed the advanced adoption of technology, evolving healthcare sectors, and increasing minimally invasive surgeries are propelling the market growth. The Indian market growth is one of the fastest-growing countries in the APAC region. The deep brain stimulation market is expected to have stable growth in India during the forecast period. A rise in the prevalence of lifestyle diseases and increasing neurological disorders are causing market growth in the country.

KEY MARKET PLAYERS:

Medtronic, Aleva Neurotherapeutics, NeuroPace, Boston Scientific, Abbott (ST. JUDE MEDICAL), Beijing Pins Medical, Neuro Sigma, Functional Neuromodulation, Fisher Wallace, NeuroSigma Company, ANM Adaptive Neuromodulation GmbH, Renishaw plc, LivaNova PLC, SceneRay Corporation, Nevro Corp., and Neuronetics, Inc. are some of the notable players operating in the global deep brain stimulation market.

These players, along with investments in the global deep brain stimulation market, are seeing their market profits, market positioning based on corporate strategies such as new solution/product launches, research initiatives, acquisitions, geographical expansions, and collaboration, which helps them in achieving their position in the Deep Brain Stimulation Market player positioning.

RECENT MARKET DEVELOPMENTS:

  • In 2019, Teijin Limited (Teijin) and NeuroSigma agreed to collaborate. (From Japan) Teijin Pharma, Teijin's healthcare business's core division, has been granted exclusive rights to market NeuroSigma's Monarch eTNS product in Japan, as well as the company's TNS patent rights for the non-invasive treatment of ADHD.
  • In 2018, Abbott and the National Institutes of Health (NIH) signed a deal. (United States). According to the agreement, Abbott will donate neuromodulation instruments, such as lateral DBS, SCS, and DRG treatment, to the NIH for research into their applications in chronic pain and progressive movement disorders.
  • In 2017, Medtronic and Mercy (US) partnered to form a virtual data sharing and testing network to help collect science data for medical device innovation and patient access.
  1. Introduction                                                          
    1. Market Definition                                               
    2. Scope of the report                                            
    3. Study Assumptions
    4. Base Currency, Base Year and Forecast Periods
  2. Research Methodology
    1. Analysis Design
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Data Modelling
      4. Expert Validation
    3. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking
      1. Market share analysis
      2. Products/Service
      3. Regional Presence
    2. Mergers & Acquisition Landscape
    3. Joint Ventures & Collaborations
  6. Market Segmentation
    1. Deep Brain Stimulation Market, By Product
      1. Single Channel
      2. Dual-Channel
      3. Market Size Estimations & Forecasts (2021-2026)
      4. Y-o-Y Growth Rate Analysis
      5. Market Attractiveness Index
    2. Deep Brain Stimulation Market, By Type
      1. Subthalamic DBS
      2. Globus Pallidus DBS
      3. Thalamic DBS
      4. Pedunculopontine Nucleus DBS
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
    3. Deep Brain Stimulation Market, By Application
      1. Pain Management
      2. Epilepsy
      3. Essential Tremor
      4. Obsessive-Compulsive Disorder (OCD)
      5. Depression
      6. Dystonia
      7. Parkinson’s Disease
      8. Others
      9. Market Size Estimations & Forecasts (2021-2026)
      10. Y-o-Y Growth Rate Analysis
      11. Market Attractiveness Index
    4. Deep Brain Stimulation Market, By End User
      1. Hospitals
      2. Neurology Clinics
      3. Ambulatory Surgical Centres
      4. Research Centres
      5. Market Size Estimations & Forecasts (2021-2026)
      6. Y-o-Y Growth Rate Analysis
      7. Market Attractiveness Index
  7. Geographical Landscape
    1. Global Deep Brain Stimulation Market, by Region
    2. North America - Market Analysis (2021 to 2026)
      1. By Country
        1. USA
        2. Canada
    3. Europe                                                   
      1. By Country
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
    4. Asia Pacific                                             
      1. By Country
        1. China                  
        2. India
        3. Japan                  
        4. South Korea
        5. Southeast Asia
        6. Australia & NZ
        7. Rest of Asia- Pacific
    5. Latin America
      1. By Country
        1. Brazil
        2. Argentina
        3. Mexico                
        4. Rest of Latin America
    6. The Middle East and Africa
      1. By Country
        1. Middle East
        2. Africa
  8. Key Player Analysis
    1. Medtronic
      1. Business Description
      2. Products/Service
      3. Financials                             
      4. SWOT Analysis
      5. Recent Developments
      6. Analyst Overview
    2. Aleva Neurotherapeutics
    3. NeuroPace
    4. Boston Scientific
    5. Abbott (ST. JUDE MEDICAL)
    6. Beijing Pins Medical
    7. Neuro Sigma
    8. Functional Neuromodulation
    9. Fisher Wallace
    10. NeuroSigma Company
    11. ANM Adaptive Neuromodulation GmbH
    12. Renishaw plc
    13. LivaNova PLC
    14. SceneRay Corporation
    15. Nevro Corp.
    16. Neuronetics, Inc.
  9. Market Outlook & Investment Opportunities
  10. Appendix                                               
    1. List of Tables
    2. List of Figures
  • Global, Regional, and Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and identifying the regions that are still untapped.
  • The segment-level analysis in terms of type, product, application and end-user and market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, including broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players and their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field, new product launches, comparative financial studies, and recent developments in the market by major companies.
  • An executive summary abridges the entire report so that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview and investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Deep Brain Stimulation Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  3. Global Subthalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Globus Pallidus DBS Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Thalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Pedunculopontine Nucleus DBS Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  8. Global Pain Management Market, By Region, From 2021 to 2026 (USD Million)
  9. Global Epilepsy Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Essential Tremor Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Obsessive-Compulsive Disorder (OCD) Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Depression Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Dystonia Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Parkinson’s Disease Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Others Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  17. Global Single Channel Market, By Region, From 2021 to 2026 (USD Million)
  18. Global Dual-Channel Market, By Region, From 2021 to 2026 (USD Million)
  19. Global Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  20. Global Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  21. Global Neurology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  22. Global Ambulatory Surgical Centres Market, By Region, From 2021 to 2026 (USD Million)
  23. Global Research Centres Market, By Region, From 2021 to 2026 (USD Million)
  24. North America Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  25. North America Subthalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Globus Pallidus DBS Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Thalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Pedunculopontine Nucleus DBS Market, By Region, From 2021 to 2026 (USD Million)
  29. North America Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  30. North America Pain Management Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Epilepsy Market, By Region, From 2021 to 2026 (USD Million)
  32. North America Essential Tremor Market, By Region, From 2021 to 2026 (USD Million)
  33. North America Obsessive-Compulsive Disorder (OCD) Market, By Region, From 2021 to 2026 (USD Million)
  34. North America Depression Market, By Region, From 2021 to 2026 (USD Million)
  35. North America Dystonia Market, By Region, From 2021 to 2026 (USD Million)
  36. North America Parkinson’s Disease Market, By Region, From 2021 to 2026 (USD Million)
  37. North America Others Market, By Region, From 2021 to 2026 (USD Million)
  38. North America Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  39. North America Single Channel Market, By Region, From 2021 to 2026 (USD Million)
  40. North America Dual-Channel Market, By Region, From 2021 to 2026 (USD Million)
  41. North America Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  42. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  43. North America Neurology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  44. North America Ambulatory Surgical Centres Market, By Region, From 2021 to 2026 (USD Million)
  45. North America Research Centres Market, By Region, From 2021 to 2026 (USD Million)
  46. United States Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  47. United States Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  48. United States Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  49. United States Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  50. Canada Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  51. Canada Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  52. Canada Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  53. Canada Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  54. Europe Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  55. Europe Subthalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  56. Europe Globus Pallidus DBS Market, By Region, From 2021 to 2026 (USD Million)
  57. Europe Thalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  58. Europe Pedunculopontine Nucleus DBS Market, By Region, From 2021 to 2026 (USD Million)
  59. Europe Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  60. Europe Pain Management Market, By Region, From 2021 to 2026 (USD Million)
  61. Europe Epilepsy Market, By Region, From 2021 to 2026 (USD Million)
  62. Europe Essential Tremor Market, By Region, From 2021 to 2026 (USD Million)
  63. Europe Obsessive-Compulsive Disorder (OCD) Market, By Region, From 2021 to 2026 (USD Million)
  64. Europe Depression Market, By Region, From 2021 to 2026 (USD Million)
  65. Europe Dystonia Market, By Region, From 2021 to 2026 (USD Million)
  66. Europe Parkinson’s Disease Market, By Region, From 2021 to 2026 (USD Million)
  67. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  68. Europe Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  69. Europe Single Channel Market, By Region, From 2021 to 2026 (USD Million)
  70. Europe Dual-Channel Market, By Region, From 2021 to 2026 (USD Million)
  71. Europe Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  72. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  73. Europe Neurology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  74. Europe Ambulatory Surgical Centres Market, By Region, From 2021 to 2026 (USD Million)
  75. Europe Research Centres Market, By Region, From 2021 to 2026 (USD Million)
  76. U.K. Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  77. U.K. Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  78. U.K. Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  79. U.K. Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  80. Germany Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  81. Germany Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  82. Germany Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  83. Germany Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  84. France Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  85. France Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  86. France Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  87. France Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  88. Italy Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  89. Italy Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  90. Italy Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  91. Italy Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  92. Spain Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  93. Spain Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  94. Spain Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  95. Spain Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  96. Asia Pacific Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  97. Asia Pacific Subthalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  98. Asia Pacific Globus Pallidus DBS Market, By Region, From 2021 to 2026 (USD Million)
  99. Asia Pacific Thalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  100. Asia Pacific Pedunculopontine Nucleus DBS Market, By Region, From 2021 to 2026 (USD Million)
  101. Asia Pacific Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  102. Asia Pacific Pain Management Market, By Region, From 2021 to 2026 (USD Million)
  103. Asia Pacific Epilepsy Market, By Region, From 2021 to 2026 (USD Million)
  104. Asia Pacific Essential Tremor Market, By Region, From 2021 to 2026 (USD Million)
  105. Asia Pacific Obsessive-Compulsive Disorder (OCD) Market, By Region, From 2021 to 2026 (USD Million)
  106. Asia Pacific Depression Market, By Region, From 2021 to 2026 (USD Million)
  107. Asia Pacific Dystonia Market, By Region, From 2021 to 2026 (USD Million)
  108. Asia Pacific Parkinson’s Disease Market, By Region, From 2021 to 2026 (USD Million)
  109. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  110. Asia Pacific Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  111. Asia Pacific Single Channel Market, By Region, From 2021 to 2026 (USD Million)
  112. Asia Pacific Dual-Channel Market, By Region, From 2021 to 2026 (USD Million)
  113. Asia Pacific Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  114. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  115. Asia Pacific Neurology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  116. Asia Pacific Ambulatory Surgical Centres Market, By Region, From 2021 to 2026 (USD Million)
  117. Asia Pacific Research Centres Market, By Region, From 2021 to 2026 (USD Million)
  118. Japan Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  119. Japan Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  120. Japan Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  121. Japan Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  122. China Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  123. China Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  124. China Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  125. China Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  126. India Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  127. India Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  128. India Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  129. India Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  130. Australia Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  131. Australia Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  132. Australia Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  133. Australia Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  134. South Korea Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  135. South Korea Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  136. South Korea Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  137. South Korea Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  138. Latin America Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  139. Latin America Subthalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  140. Latin America Globus Pallidus DBS Market, By Region, From 2021 to 2026 (USD Million)
  141. Latin America Thalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  142. Latin America Pedunculopontine Nucleus DBS Market, By Region, From 2021 to 2026 (USD Million)
  143. Latin America Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  144. Latin America Pain Management Market, By Region, From 2021 to 2026 (USD Million)
  145. Latin America Epilepsy Market, By Region, From 2021 to 2026 (USD Million)
  146. Latin America Essential Tremor Market, By Region, From 2021 to 2026 (USD Million)
  147. Latin America Obsessive-Compulsive Disorder (OCD) Market, By Region, From 2021 to 2026 (USD Million)
  148. Latin America Depression Market, By Region, From 2021 to 2026 (USD Million)
  149. Latin America Dystonia Market, By Region, From 2021 to 2026 (USD Million)
  150. Latin America Parkinson’s Disease Market, By Region, From 2021 to 2026 (USD Million)
  151. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  152. Latin America Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  153. Latin America Single Channel Market, By Region, From 2021 to 2026 (USD Million)
  154. Latin America Dual-Channel Market, By Region, From 2021 to 2026 (USD Million)
  155. Latin America Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  156. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  157. Latin America Neurology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  158. Latin America Ambulatory Surgical Centres Market, By Region, From 2021 to 2026 (USD Million)
  159. Latin America Research Centres Market, By Region, From 2021 to 2026 (USD Million)
  160. Brazil Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  161. Brazil Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  162. Brazil Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  163. Brazil Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  164. Argentina Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  165. Argentina Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  166. Argentina Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  167. Argentina Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  168. Mexico Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  169. Mexico Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  170. Mexico Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  171. Mexico Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  172. Rest of Latin America Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  173. Rest of Latin America Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  174. Rest of Latin America Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  175. Rest of Latin America Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  176. Middle East and Africa Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  177. Middle East and Africa Subthalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  178. Middle East and Africa Globus Pallidus DBS Market, By Region, From 2021 to 2026 (USD Million)
  179. Middle East and Africa Thalamic DBS Market, By Region, From 2021 to 2026 (USD Million)
  180. Middle East and Africa Pedunculopontine Nucleus DBS Market, By Region, From 2021 to 2026 (USD Million)
  181. Middle East and Africa Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  182. Middle East and Africa Pain Management Market, By Region, From 2021 to 2026 (USD Million)
  183. Middle East and Africa Epilepsy Market, By Region, From 2021 to 2026 (USD Million)
  184. Middle East and Africa Essential Tremor Market, By Region, From 2021 to 2026 (USD Million)
  185. Middle East and Africa Obsessive-Compulsive Disorder (OCD) Market, By Region, From 2021 to 2026 (USD Million)
  186. Middle East and Africa Depression Market, By Region, From 2021 to 2026 (USD Million)
  187. Middle East and Africa Dystonia Market, By Region, From 2021 to 2026 (USD Million)
  188. Middle East and Africa Parkinson’s Disease Market, By Region, From 2021 to 2026 (USD Million)
  189. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Million)
  190. Middle East and Africa Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  191. Middle East and Africa Single Channel Market, By Region, From 2021 to 2026 (USD Million)
  192. Middle East and Africa Dual-Channel Market, By Region, From 2021 to 2026 (USD Million)
  193. Middle East and Africa Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  194. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  195. Middle East and Africa Neurology Clinics Market, By Region, From 2021 to 2026 (USD Million)
  196. Middle East and Africa Ambulatory Surgical Centres Market, By Region, From 2021 to 2026 (USD Million)
  197. Middle East and Africa Research Centres Market, By Region, From 2021 to 2026 (USD Million)
  198. Middle East Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  199. Middle East Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  200. Middle East Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  201. Middle East Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)
  202. Africa Deep Brain Stimulation Market, By Type, From 2021 to 2026 (USD Million)
  203. Africa Deep Brain Stimulation Market, By Application, From 2021 to 2026 (USD Million)
  204. Africa Deep Brain Stimulation Market, By Product, From 2021 to 2026 (USD Million)
  205. Africa Deep Brain Stimulation Market, By End-Use, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample